既往妊娠期糖尿病女性的肾脏疾病:一项全国性登记队列研究
这项丹麦全国性登记队列研究纳入1997至2018年间分娩的全部女性共697,622例,中位随访11.9年。妊娠期糖尿病与慢性肾脏病风险升高相关(aHR 1.92;95%CI 1.67-2.21),与急性肾脏病无关;糖尿病和高血压分别介导75.7%和30.3%的关联;接受胰岛素治疗的妊娠期糖尿病且后续无糖尿病者慢性肾脏病风险最高。
要点
- 妊娠期糖尿病与慢性肾脏病风险升高相关,aHR 1.92(95%CI 1.67-2.21),与急性肾脏病无关。
- 糖尿病和高血压分别介导妊娠期糖尿病与慢性肾脏病关联的75.7%和30.3%。
- 接受胰岛素治疗的妊娠期糖尿病且后续无糖尿病者,慢性肾脏病风险较无妊娠期糖尿病者升高(aHR 2.35;95%CI 1.39-3.97)。
核心结论
- 妊娠期糖尿病后慢性肾脏病风险显著升高,与后续是否发生糖尿病和高血压无关;妊娠期代谢功能障碍严重者慢性肾脏病风险最高。
研究设计与样本
- 丹麦全国性登记队列研究,纳入1997至2018年间分娩的全部女性,共697,622例,中位随访11.9年。
- 采用Cox回归分析妊娠期糖尿病与肾脏疾病的关联,以妊娠期糖尿病诊断及胰岛素治疗作为妊娠期代谢功能障碍严重程度的替代指标并作为交互项纳入模型。
- 采用中介分析量化后续糖尿病和高血压在肾脏疾病之前的中介效应。
主要发现
- 妊娠期糖尿病与慢性肾脏病风险升高相关(aHR 1.92;95%CI 1.67-2.21),急性肾脏病与妊娠期糖尿病无关。
- 中介分析显示,糖尿病和高血压对妊娠期糖尿病与慢性肾脏病关联的间接效应比例分别为75.7%(95%CI 61.8-89.6)和30.3%(95%CI 25.2-35.4)。
- 与无妊娠期糖尿病女性相比,接受胰岛素治疗的妊娠期糖尿病且后续无糖尿病者慢性肾脏病风险显著升高(aHR 2.35;95%CI 1.39-3.97)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The association between gestational diabetes mellitus (GDM) and incident kidney disease, the mediating effects of diabetes and hypertension, and the impact of severity of metabolic dysfunction during pregnancy on the risk of incident kidney disease were investigated in this study. RESEARCH DESIGN AND METHODS: This Danish, nationwide, register-based cohort study included all women giving birth between 1997 and 2018. Outcomes included chronic kidney disease (CKD) and acute kidney disease, based on diagnosis codes. Cox regression analyses explored the association between GDM and kidney disease. A proxy for severity of metabolic dysfunction during pregnancy was based on GDM diagnosis and insulin treatment during GDM in pregnancy and was included in the models as an interaction term. The mediating effects of subsequent diabetes and hypertension prior to kidney disease were quantified using mediation analyses. RESULTS: Data from 697,622 women were used. Median follow-up was 11.9 years. GDM was associated with higher risk of CKD (adjusted hazard ratio [aHR] 1.92; 95% CI 1.67-2.21), whereas acute kidney disease was unrelated to GDM. The proportions of indirect effects of diabetes and hypertension on the association between GDM and CKD were 75.7% (95% CI 61.8-89.6) and 30.3% (95% CI 25.2-35.4), respectively, as assessed by mediation analyses. The CKD risk was significantly increased in women with insulin-treated GDM and no subsequent diabetes compared with women without GDM (aHR 2.35; 95% CI 1.39-3.97). CONCLUSIONS: The risk of CKD was significantly elevated after GDM irrespective of subsequent development of diabetes and hypertension. Furthermore, women with severe metabolic dysfunction during pregnancy had the highest CKD risk.
引用
- Christensen MH, Bistrup C, Rubin KH, et al. Kidney Disease in Women With Previous Gestational Diabetes Mellitus: A Nationwide Register-Based Cohort Study. Diabetes Care. 2024. PMID: 38100751. doi:10.2337/dc23-1092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。